MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Mesoblast limited Company Profile (NASDAQ:MESO)

Consensus Ratings for Mesoblast limited (NASDAQ:MESO) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $9.88 (38.69% upside)

Analysts' Ratings History for Mesoblast limited (NASDAQ:MESO)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016Maxim GroupReiterated RatingBuy$18.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$9.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Chardan CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Credit SuisseInitiated CoverageOutperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Ladenburg ThalmannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha